Notably, recent studies have reported that RS malignant cells exhibit reduced BCR signaling compared with CLL cells, suggesting that alternative mechanisms may sustain NF-κB activity in RS [21]. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.